Skip to content

Clinical trials

Observational Pulmonary Arterial Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Phase: Observational Country / region: United States Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20071
20083
20092
20101
20115
20122
20135
20143
20154
20163
20172
20192
20203
20216
20224
20234
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Recruiting7
Terminated7
Unknown status4
Withdrawn2
Active, not recruiting2
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion6
United Therapeutics6
Mayo Clinic5
Northwell Health3
Vanderbilt University Medical Center3
Bayer2
Silverleaf Medical Sciences INC2
University of California, Los Angeles2
University of Florida2
University of Kansas Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension59
Hypertension, Pulmonary18
Heart Failure5
Familial Primary Pulmonary Hypertension4
Hypertension4
Lung Diseases, Interstitial3
Arrhythmias, Cardiac2
Hemophilia A2
Hyperaldosteronism2
Hypokalemia2

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.